Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-30T20:18:33.906Z Has data issue: false hasContentIssue false
  • English
  • Français

What a psychiatrist needs to know about diabetes

Published online by Cambridge University Press:  16 April 2020

B. Charbonnel
B. Charbonnel*
Affiliation:
Clinique d'endocrinologie, 44000Nantes cedex, France
*
E-mail address: bernard.charbonnel @ sante.univ-nantes.fr (B. Charbonnel).
Get access

Abstract

Diabetes mellitus is a complex metabolic disorder, caused by defects in insulin action and/or insulin production and is defined as afasting hyperglycaemia of >126 mg/dl, with normoglycaemia being ≥70 and ≤ 110 mg/dl. There are two main types of diabetes. Type 1 diabetes (around 10% of cases) is an autoimmune disease, usually of early onset, in which pancreatic islet beta cells that secrete insulin are destroyed. Type 2 diabetes (around 85% of cases) is characterised principally by insulin resistance and impaired insulin secretion. Heredity and obesity are major risk factors for Type 2 diabetes. Diabetes is associated with potentially life-threatening microvascular and macrovascular complications caused by elevated serum glucose levels. Treatment of diabetes aims at restoring glycaemic control. In Type 1 diabetes, this can be achieved by injecting insulin. Oral hypoglycaemic medications that stimulate insulin secretion and/or modify glucose metabolism can be used as a first-line treatment in Type 2 diabetes mellitus. However, insulin is usually necessary in later phases of the disease. Lifestyle changes, such as diet and exercise, are also important. Glycaemic control can be measured by fasting blood glucose levels and also by glycosylated haemoglobin levels. The latter measure gives an indication of glycaemic control over a period of three months, and a reduction in glycosylated haemoglobin is the most appropriate treatment goal in the management of diabetes.

Keywords

PsychiatristDiabetesMetabolic disorder
Type
Research Article
Information
European Psychiatry , Volume 20 , Issue S4 , December 2005 , pp. S330 - S334
Copyright
Copyright © European Psychiatric Association 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alberti K.G.M.N.,Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. 1999 "http://whglibdoc.who.int/hq/I999/WHO_NCD_NCS_99.2.pdf"Google Scholar
American Diabetes Association Diabetic nephropathy. Diabetes Care. 2003;Suppl 1: s94-s8CrossRefGoogle Scholar
American Diabetes Association Management of dyslipidemia in adults with diabetes. Diabetes Care. 2003;Suppl 1: S83–S86CrossRefGoogle Scholar
American Diabetes Association Tests of glycemia in diabetes. Diabetes Care. 2003;Suppl 1: S106-s8CrossRefGoogle Scholar
Amos, A.F.McCarty, D.J.Zimmet, P.The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997; 14: S1–S853.3.CO;2-I>CrossRefGoogle ScholarPubMed
Caputo, G.M.Cavanagh, P.R.Ulbrecht, J.S.Gobbons, G.W.Karchmer, A.W.Assessment and management of foot disease in patients with diabetes. N Eng J Med. 1994; 331: 854–860CrossRefGoogle ScholarPubMed
Colditz, G.A.Willett, W.C.Rotnitzky, A.Manson, J.E.Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995; 122: 481–486CrossRefGoogle ScholarPubMed
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003; 26 Suppl 1: S5–S20CrossRefGoogle Scholar
Holtzer, S.E.Camerota, A.Martens, L.Cuerdon, T.Crystalpeters, J.Zagari, M.Cost and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther. 1998; 20: 169-81Google Scholar
LeRoith D. B-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities. 2002CrossRefGoogle Scholar
Mahnberg, K.Yusuf, S.Gerstein, H.C.Brown, J.Zhao, F.Hunt, D., et al.Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organizationto Assess Strategies for Ischemic Syndromes) Registry. Circulation. 2000; 102: 1014-9Google Scholar
Ohkubo, Y.Kishikawa, H.Araki, E.Miyata, T.Isami, S.Motoyoshi, S., et al.Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetesmellitus: a randomised prospective 6-year study. Diabetes Res Clin Pract. 1995; 28: 103-17CrossRefGoogle Scholar
Rohfling, C.L.Wiedmeyer, H.-M.Little, R.R.England, J.D.Tenill, A.Goldstein, E.Defining the relationship between plasma glucose and HbAIC: analysis of glucose profiles and HbAIC in the Diabetes Control and Complications Trial. Diabetes Care. 2002; 25: 275-8Google Scholar
Ryan, M.C.Thakore, J.H.Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci. 2002; 71: 239-57CrossRefGoogle ScholarPubMed
Shichiri, M.Kishikawa, H.Ohkubo, Y.Wake, N.Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;Suppl 2: B21-9Google Scholar
Skyler, I.S.Diabetic complications. The importance of glucose control. Endocrinol Metab Clin North Am. 1996; 25: 243-54CrossRefGoogle ScholarPubMed
Stratton, I.M.Adler, A.I.Neil, A.W.Matthews, D.R.Mansley, S.E.Cull, C.A., et al.UK Prospective Diabetes Study GroupAssociation of glycaemia with microvascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321: 405-12CrossRefGoogle ScholarPubMed
United Kingdom Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes (UKPDS 33). Lancet. 1998; 352: 837-53CrossRefGoogle Scholar
United States Renal Data System USRDS 2000 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2000Google Scholar
Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of Diabetes Mellitus. 1999 http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf"Available atGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.